Cancer Control and Population Sciences

癌症控制与人口科学项目 摘要 癌症控制和人口科学(CCPS)计划的使命是推动科学和 癌症病因学、预防和结果研究的应用。其目标是减轻癌症的负担 以及它的后遗症，通过多学科的协作努力惠及所有人口阶层。要实现 为了实现这一目标，该计划有三个主题：1)发现导致癌症的宿主和环境因素； 2)确定降低癌症治疗中与健康相关的发病率和死亡率的因素；以及3)开发、 实施和评估旨在降低癌症相关发病率/死亡率和提高生活质量的干预措施 (QOL)。在这些主题中，正在进行研究，以减少我们集水区内的健康差距。 同样重要的是，每个主题都包含了强大的教育内容，从K-12课程到 社区对医疗保健提供者和照顾者的培训，以更好地沟通和照顾癌症幸存者。 具有全国知名度的有针对性的招聘人员为该计划增加了深度和广度，其中包括Dr。 希沃特、克勒博斯基、格雷、基特尔斯和易。CCPS计划特别投资于以下关键 领域：建立强大的癌症病因学和生物标记物开发研究组合；加强 重点了解治疗相关并发症的风险因素，并制定量身定制的干预措施 降低癌症幸存者的发病率；识别疾病类型和疾病特有的预后差异的原因 制定有针对性的干预措施，系统地缩小差距；并继续在强大的 在心理社会结果和量身定制的干预措施方面的研究组合，以改善生活质量。赞助活动 包括每月进行中的工作会议、每月研讨会、年度务虚会和年度试点资金。 成员：23名计划成员，代表4个基础和临床科室 出版物：总计410份。34.6%的方案内；20.2%的方案间；58.0%的机构间 资金：7,770,700美元经同行审查；其中5,788,708美元为NCI资金

Cancer Control and Population Sciences Program ABSTRACT The mission of the Cancer Control and Population Sciences (CCPS) Program is to advance the science and application of cancer etiology, prevention, and outcomes research. The goal is to reduce the burden of cancer and its sequelae across all segments of the population through collaborative, multidisciplinary efforts. To achieve this goal, the Program has three themes: 1) To discover host and environmental factors contributing to cancer; 2) To identify factors to reduce health-related morbidity and mortality from cancer treatment; and 3) To develop, implement and evaluate interventions to reduce cancer-related morbidity/mortality and improve quality of life (QOL). Within each of these themes, research is on-going to reduce health disparities within our catchment area. As importantly, each theme encompasses strong education components ranging from K-12 programs in the community to healthcare provider and caregiver training for better communication and care for cancer survivors. Targeted recruits with national prominence add both depth and breadth to the Program and include Drs. Seewaldt, Chlebowski, Gray, Kittles, and Yee. The CCPS Program is particularly invested in the following key areas: building a robust portfolio of research in cancer etiology and biomarker development; strengthening the focus on understanding risk factors for treatment-related complications and developing tailored interventions to reduce morbidity in cancer survivors; recognizing causes of disparities in outcome unique to disease type and developing tailored interventions to systematically mitigate the disparities; and continuing to build upon the strong portfolio of research in psychosocial outcomes and tailored interventions to improve QOL. Sponsored activities include monthly work in progress meetings, monthly seminars, an annual retreat, and annual pilot funding. Membership: 23 Program Members representing 4 basic and clinical departments Publications: 410 total. 34.6% intra-programmatic; 20.2% inter-programmatic; 58.0% inter-institutional Funding: $7,770,700 peer-reviewed; $5,788,708 of which is NCI funding